✦ LIBER ✦

Advances in treatment of chronic myelogenous leukemia – new treatment options with tyrosine kinase inhibitors

✍ Scribed by Santos, Fabio P. S.; Ravandi, Farhad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nilotinib: A New Tyrosine Kinase Inhibit

✍ Anthony Jarkowski; Richard P. Sweeney 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Resistance to Tyrosine Kinase Inhibition

✍ Jabbour, Elias J.; Cortes, Jorge E.; Kantarjian, Hagop M. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 545 KB

Current Status and Perspectives of Tyros

✍ Evgeny Klyuchnikov; Nicolaus Kröger; Tim H. Brummendorf; Bettina Wiedemann; Axel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Tyrosine kinase inhibitors and gemcitabi

✍ Axel Kleespies; Karl-Walter Jauch; Christiane J. Bruns 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Class effects of tyrosine kinase inhibit

✍ Giles, F J; O'Dwyer, M; Swords, R 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 315 KB

Impact of comorbidities on the treatment

✍ Gugliotta, Gabriele; Castagnetti, Fausto; Fogli, Miriam; Cavo, Michele; Baccaran 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 320 KB